Industry

MINNEAPOLIS–(BUSINESS WIRE)–DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that the company’s management team will be participating in one-on-one meetings at the upcoming BTIG Biotechnology Conference, which is taking place both virtually and at the St. Regis New York Hotel in … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–$ARCT #ClinicalTrial–Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global, late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it will release its financial results for the quarter ended June 30, 2022 after the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Amyloid precursor protein secretase inhibitors – Pipeline Insight, 2022” report has been added to ResearchAndMarkets.com’s offering. This “Amyloid precursor protein secretase inhibitors – Pipeline Insight, 2022” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Amyloid precursor protein secretase inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical … [Read more…]

Zelis accelerates mission of making care more affordable and transparent for all with Payer Compass’s advanced technology for claims management BEDMINSTER, N.J.–(BUSINESS WIRE)–Zelis, a leading healthcare payments and pricing company, announced today it entered into a definitive agreement to acquire Payer Compass, one of the healthcare industry’s leading providers of reimbursement and claims pricing, administration, … [Read more…]

NEW HYDE PARK, N.Y.–(BUSINESS WIRE)–Northwell Health today announced the appointment of Sophy Lu as its new chief information officer (CIO). Ms. Lu, a 12-year veteran of the health system, succeeds John Bosco, who held the post from 2004 until his retirement. Ms. Lu, a senior vice president who previously served as deputy CIO, will oversee … [Read more…]

SEATTLE–(BUSINESS WIRE)–Frazier Healthcare Partners, a leading private equity and venture capital firm focused exclusively on the healthcare industry, is pleased to announce that Amy DuRoss has joined the firm’s Growth Buyout team as a Senior Advisor. In this role, Ms. DuRoss will help the firm build and execute investment strategies to serve the growing pharmaceutical … [Read more…]

YONGIN, South Korea–(BUSINESS WIRE)–GC Biopharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited consolidated financial results for the three months ended 30 June 2022. Second-Quarter Reported Results Key Figures Q2 2022 Growth(1) Total revenues KRW 423.2 billion 9.2% Operating Income KRW 13.1 billion 18.0% Net Income KRW … [Read more…]

LONDON–(BUSINESS WIRE)–#businesstravel–Many countries are recording an increase in dengue. Over the last 20 years, cases have risen more than 8 fold, impacting tens of millions of people globally1. International SOS, the world’s leading security and health services company, has seen a 92% increase in dengue-related cases this year compared to last year and therefore encourages … [Read more…]

Company Expands into Southeast with Raleigh, North Carolina Purchase ANNAPOLIS, Md.–(BUSINESS WIRE)–Thomas Park Investments closed the first half of 2022 with $75 million in medical office building (MOB) acquisitions, halfway toward the company’s goal of $150 million in acquisitions this year. The acquisitions include a purchase in Raleigh, North Carolina, signaling the company’s expansion into … [Read more…]

No dose-limiting toxicities or significant treatment-related adverse events were observed for any patient at any dose level WARREN, N.J.–(BUSINESS WIRE)–#COVID19—Tevogen Bio, a late stage clinical biotechnology company specializing in the development of cell and gene therapies in oncology, neurology, and virology, today announced that it completed enrollment in the Proof-of-Concept clinical trial of the company’s … [Read more…]